Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: A possible role of hyperforin

Behavioural Brain Research

Volumn 199, Issue 2, 2009, Pages 334-339

  Tadros, Mariane G ^a   Mohamed, Mohamed R ^b   Youssef, Amal M ^c   Sabry, Gilane M ^b   Sabry, Nagwa A ^a   Khalifa, Amani E ^a  

^a Ain Shams University   (Egypt)

^b Ain Shams University   (Egypt)

^c Suez Canal University   (Egypt)

Author keywords

Dopamine; Hyperforin; Noradrenaline; Prepulse inhibition (PPI); Serotonin; St. John's wort

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BRAIN MONOAMINE; DOPAMINE 1 RECEPTOR; HYPERFORIN; HYPERICIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DNA ISOLATION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG MECHANISM; ELECTROPHORESIS; HYPERICUM PERFORATUM; MALE; MONOAMINERGIC SYSTEM; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SENSORIMOTOR FUNCTION; SEROTONINERGIC SYSTEM; STARTLE REFLEX;

ANIMALS; APOPTOSIS; BICYCLO COMPOUNDS; DNA FRAGMENTATION; DRUGS, CHINESE HERBAL; HYPERICUM; INHIBITION (PSYCHOLOGY); MALE; MICE; PERYLENE; PHLOROGLUCINOL; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, DOPAMINE D1; REFLEX, ACOUSTIC; STARTLE REACTION; TERPENES;

EID: 61349182494     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.12.015     Document Type: Article

References (57)

1. Alsene K.M., Carasso B.S., Connors E.E., and Bakshi V.P. Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors. Neuropsychopharmacology 31 10 (2006) 2150-2161
2. Agapitov A.V., Correia M.L., Sinkey C.A., and Haynes W.G. Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 52 4 (2008) 687-695
3. Auclair A.L., Galinier A., Besnard J., Newman-Tancredi A., and Depoortere R. Putative antipsychotics with pronounced agonism at Serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. Psychopharmacology 193 1 (2007) 45-54
4. Barr A.M., Lehmann-Masten V., Paulus M., Gainetdinov R.R., Caron M.G., and Geyer M.A. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29 2 (2004) 221-228
5. Barr A.M., Powell S.B., Markou A., and Geyer M.A. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology 51 3 (2006) 457-465
6. Bombardelli E., and Morazzoni P. Hypericum perforatum. Fitoterapia 66 (1995) 43-68
7. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia: Human and animal model studies. Arch Gen Psychiatry 47 (1990) 181-188
8. Calapai G., Crupi A., Firenzuoli F., Costantino G., Inferrera G., Campo G.M., et al. Effect of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalons and brainstem of the rat. Pharm Pharmacol 51 (1999) 723-728
9. Calapai G., Crupi A., Firenzuoli F., Inferrera G., Squadrito F., Parisi A., et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum. Pharmacopsychiatry 34 (2001) 45-49
10. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., and Müller W.E. Hyperforin as possible antidepressant component of Hypericum extracts. Life Sci 63 (1998) 499-510
11. Chatterjee S.S., Noldner M., Koch E., and Erdelmeier C. Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 31 (1998) 7-15
12. Chugh Y., Saha N., Sankaranarayanan A., and Datta H. Enhancement of memory retrieval and attenuation of scopolamine-induced amnesia following administration of 5-HT3 antagonist ICS 205-930. Pharmacol Toxicol 69 (1991) 105-106
13. Coskun I., Tayfun Uzbay I., Ozturk N., and Ozturk Y. Attenuation of ethanol withdrawal syndrome by extract of Hypericum perforatum in Wistar rats. Fundam Clin Pharmacol 20 5 (2006) 481-488
14. da Silva A.L., Ferreira J.G., da Silva M.B., Oliveira S., Mai N., Nunes D.S., et al. Serotonin receptors contribute to the promnesic effects of P. olacoides (Marapuama). Physiol Behav 95 1-2 (2008) 88-92
15. deJong I.E., and van den Buuse M. SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats. Neuropharmacology 51 3 (2006) 438-446
16. Di Matteo V., Di Giovanni G., Di Mascio M., and Esposito E. Effect of acute administration of Hypericum perforatum extract on dopamine and serotonin release in rat central nervous system. Pharmacopsychiatry 33 (2000) 14-18
17. Dona M., Dell'Aica I., Pezzato E., Sartor L., Calabrese F., Barbera M.D., et al. Hyperforin inhibits cancer invasion and metastasis. Cancer Res 64 17 (2004) 6225-6232
18. Ellenbroek B.A., Lubbers L.J., and Cools A.R. The role of hippocampal dopamine receptors in prepulse inhibition. Eur J Neurosci 15 7 (2002) 1237-1243
19. El-Sherbiny D.A., Khalifa A.E., Attia A.S., and Eldenshary E.E. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 76 3-4 (2003) 525-533
20. Feifel D., Melendez G., and Shilling P.D. A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist. Neuropsychopharmacology 28 4 (2003) 651-653
21. Fendt M., and Koch M. Cholinergic modulation of the acoustic startle response in the caudal pontine reticular nucleus of the rat. Eur J Pharmacol 370 (1999) 101-107
22. Gobbi M., Dalla Valle F., Ciapparelli C., Diomede L., Morazzoni P., Verotta L., et al. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex. Naunyn-Schmiedebergs Arch Pharmacol 360 3 (1999) 262-269
23. Gogos A., Kusljic S., and van den Buuse M. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacol Biochem Behav 81 3 (2005) 664-672
24. Hasler F, Studerus E, Lindner K, Ludewig S, Vollenweider F. Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. J Psychopharmacol 2008 Jul 17, in press.
25. Hawkins M.F., Uzelac S.M., Hearn J.K., and Baumeister A.A. Effects of selective serotonin(2) ligands on behaviors evoked by stress in the rat. Pharmacol Biochem Behav 90 4 (2008) 632-639
26. Hirano K., Kato Y., Uchida S., Sugimoto Y., Yamada J., Umegaki K., et al. Effects of oral administration of extracts of Hypericum perforatum (St. John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice. J Pharm Pharmacol 56 12 (2004) 1589-1595
27. Hostanska K., Reichling J., Bommer S., Weber Mand, and Saller R. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur J Pharm Biopharm 56 1 (2003) 121-132
28. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus-maze for dissociation of amnestic and behavioral effects of drugs in mice. Eur J Pharmacol 194 (1991) 71-76
29. Jiang X.Z., Li Y.F., Zhang Y.Z., Chen H.X., Li J., and Wang N.P. 5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine. Yao Xue Xue Bao 43 5 (2008) 467-473
30. Khalifa A.E. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. J Ethnopharmacol 76 (2001) 49-57
31. Khalifa A.E. Neural monoaminergic mediation of the effect of St. John's wort extract on prepulse inhibition of the acoustic startle response in rats. J Psychopharmacol 19 5 (2005) 467-472
32. Kiyatkin E.A. Brain temperature responses to salient stimuli persist during dopamine receptor blockade despite a blockade of locomotor responses. Pharmacol Biochem Behav 91 2 (2008) 233-242
33. Krebs-Thomson K., Ruiz E.M., Masten V., Buell M., and Geyer M.A. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology (Berl) 189 3 (2006) 319-329
34. Lahdesmaki J., Sallinen J., MacDonald E., and Scheinin M. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29 7 (2004) 1282-1293
35. Miller A.L. St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions. Altern Med Rev 3 (1998) 18-26
36. Misane I., and Ogren S.O. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22 (2000) 168-190
37. Mjörndal T., and Persson S. The relation between spiperone binding, behavioural changes, and in vivo tyrosine hydroxylation in the rat striatum. Naunyn-Schmiedebergs Arch Pharmacol 322 2 (1983) 136-139
38. Muller W.E., Rolli M., Schafer C., and Hafner U. Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30 (1997) 102-107
39. Müller W.E., Singer A., Wonnemann M., Hafner U., Rolli M., and Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry 31 (1998) 16-21
40. Nahrstedt A., and Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 30 (1997) 129-134
41. Norenberg M.D., and Rao K.V. The mitochondrial permeability transition in neurologic disease. Neurochem Int 50 7-8 (2007) 983-997
42. Qu W.M., Huang Z.L., Xu X.H., Matsumoto N., and Urade Y. Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 28 34 (2008) 8462-8469
43. Rigdon G.C., and Weatherspoon J.K. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263 2 (1992) 486-493
44. Sastry C.S., Sailaja A., and Rao T.T. Sensitive spectrophotometric methods for the determination of pindolol. Microchim Acta 107 1-2 (1992) 1-9
45. Sato S., Gobbel G.T., Honkaniemi J., Li Y., Kondo T., Murakami K., et al. Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic. Brain Res 745 1-2 (1997) 343-347
46. Schempp C.M., Kirkin V., Simon-Haarhaus B., Kersten A., Kiss J., Termeer C.C., et al. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 21 8 (2002) 1242-1250
47. Schroeder C., Tank J., Goldstein D.S., Stoeter M., Haertter S., Luft F.C., et al. Influence of St. John's wort on catecholamine turnover and cardiovascular regulation in humans. Clin Pharmacol Ther 76 5 (2004) 480-489
48. Shishkina G.T., Kalinina T.S., Popova N.K., and Dygalo N.N. Influence of neonatal short-term reduction in brainstem alpha2A-adrenergic receptors on receptor ontogenesis, acoustic startle reflex, and prepulse inhibition in rats. Behav Neurosci 118 6 (2004) 1285-1292
49. Simón V.M., Parra A., Miñarro J., Arenas M.C., Vinader-Caerols C., and Aguilar M.A. Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice. Eur Neuropsychopharmacol 10 3 (2000) 159-164
50. +1. J Pharmacol Exp Ther 290 3 (1999) 1363-1368
51. Swerdlow N.R. Cortico-striatal substrates of cognitive, motor and sensory gating: speculations and implications for psychological function and dysfunction. In: Panksepp J. (Ed). Advances in biological psychiatry vol 2 (1996), JAI Press Inc., Greenwich, CT 179-208
52. Townshend A., Murillo Pulgarín J.A., and Alañón Pardo M.T. Flow injection-chemiluminescence determination of propranolol in pharmaceutical preparations. Anal Chim Acta 488 1 (2003) 81-88
53. Vollenweider F.X., Csomor P.A., Knappe B., Geyer M.A., and Quednow B.B. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Neuropsychopharmacology 32 9 (2007) 1876-1887
54. Yu P.H. Effect of Hypericum perforatum extract on serotonin turnover in the mouse brain. Pharmacopsychiatry 33 (2000) 60-65
55. Zarrindast M., Mohaddess G., and Rezvani-Pour M. Effect of nicotine on sniffing induced by dopaminergic receptor stimulation. Eur Neuropsychopharmacol 10 5 (2000) 397-400
56. Zarrindast M.R., Hodjati M.R., Pejhan A., and Soleimannejad E. Bupropion induces sniffing: a possible dopaminergic mechanism. Eur Neuropsychopharmacol 6 4 (1996) 299-303
57. Zarrindast M.R., Misaghi S., and Ahmadi S. The dopaminergic system plays a role in the effect of lithium on inhibitory avoidance memory in mice. Eur J Pharmacol 590 1-3 (2008) 198-203